Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 205-209

  Onor, Maria Luisa ^a   Saina, Marisa ^a   Trevisiol, Marianna ^a   Cristante, Tania ^a   Aguglia, Eugenio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Agitation; Atypical antipsychotics; Behavioral and psychological symptoms of dementia; Dementia; Risperidone

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHOLINESTERASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; RISPERIDONE;

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANXIETY; APATHY; APPETITE DISORDER; ARTICLE; BEHAVIOR; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA; CAREGIVER; CAREGIVER BURDEN; DELUSION; DEMENTIA; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHORIA; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GERIATRIC PATIENT; HALLUCINATION; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUESTIONNAIRE; SCORING SYSTEM; SLEEP DISORDER; SYMPTOM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; BEHAVIOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE;

EID: 33845769952     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.09.001     Document Type: Article

References (33)

1. American Psychiatric Association. DSM IV Diagnostic and Statistical Manual of Mental Disorders. 4th Ed (1994), American Psychiatric Press, Washington DC
2. Ballard C., and Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 25 1 (2006) CD003476
3. Ballard C., Margallo-Lana M., Juszczak E., Douglas S., Swann A., Thomas A., et al. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ 16,330 7496 (2005) 874
4. Bhana N., and Spencer C.M. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging 16 6 (2000) 451-471
5. Brodaty H., Ames D., Snowdon J., Woodward M., Kirwan J., Clarnette R., et al. A randomised placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 64 2 (2003) 134-143
6. Bullock R., and Saharan A. Atypical antipsychotics: experience and use in the elderly. Int J Clin Pract 56 7 (2002) 515-525
7. Clark W.S., Street J.S., Feldman P.D., and Breier A. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease. J Clin Psychiatry 62 1 (2001) 34-40
8. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
9. Davidson H.D. Pharmacologic management of aggression in elderly patients with dementia. Consult Pharm 13 Suppl A (1998) 17-23
10. De Deyn P.P., and Katz I.R. Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone. Int J Geriatr Psychiatry 15 1 (2000) 514-522
11. De Deyn P.P., Rabheru K., Rasmussen A., Bocksberger J.P., Dautzenberg P.L., Eriksson S., et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53 5 (1999) 946-955
12. Defilippi J.L., and Crismon M.L. Antipsychotic agents in patients with dementia. Pharmacotherapy 20 1 (2000) 23-33
13. Fernandez H.H., Lannon M.C., Friedman J.H., and Abbott B.P. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 15 3 (2000) 579-581
14. Fernandez H.H., Trieschmann M.E., Burke M.A., and Friedman J.H. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. J Clin Psychiatry 63 6 (2002) 513-515
15. Finkel S.I. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry 62 Suppl 21 (2001) 3-6
16. Folstein M.F., Folstein F.E., and Mc Hugh P.R. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12 (1975) 189-198
17. Gareri P., Cotroneo A., Marchisio U., Curcio M., and De Sarro G. Risperidone in the treatment of behavioral disorders in elderly patients with dementia. Arch Gerontol Geriatr, Suppl 7 (2001) 173-182
18. Green B. Focus on quetiapine. Curr Med Res Opin 15 3 (1999) 145-151
19. Herrmann N., and Lactot K. Do atypical antipsychotics cause stroke?. CNS Drugs 19 2 (2005) 91-103
20. Katz I.R., Jeste D.V., Mintzer J.E., Clyde C., Napolitano J., Brecher M., and Risperidone Study Group. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 60 2 (1999) 107-115
21. Lee P.E., Gill S.S., Freedman M., Bronskill S.E., Hillmer M.P., and Rochon P.A. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 10;329 7457 (2004) 75
22. McManus D.Q., Arvanitis L.A., and Kowalcyk B.B. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 study group. J Clin Psychiatry 60 5 (1999) 292-298
23. Menza M.M., Palermo B., and Mark M. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease. Ann Clin Psychiatry 11 3 (1999) 141-144
24. O'Donnell B.F., Drachman D.A., Barnes H.J., Peterson K.E., Swearer J.M., and Lew R.A. Incontinence and troublesome behaviors predict institutionalization in dementia. J Geriatr Psychiatry Neurol 5 1 (1992) 45-52
25. Rabins P.V., Mace N.L., and Lucas M.J. The impact of dementia on the family. JAMA 248 3 (1982) 333-335
26. Reisberg B., Borenstein J., Salob S.P., Ferris S.H., Franssen E., and Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 48 (1987) 9-15 (Suppl)
27. Scharre D.W., and Chang S.I. Cognitive and behavioral effects of quetiapine in Alzheimer disease patients. Alzheimer Dis Assoc Disord 16 2 (2002) 128-130
28. Schneider L.S., Dagerman K.S., and Insel P. Risk of death with atypical antipsychotic drug treatment for dementia. Meta-analysis of randomized placebo-controlled trials. JAMA 294 15 (2005) 1934-1943
29. Small G.W., Rabins P.V., Barry P.P., Buckholtz N.S., DeKosky S.T., Ferris S.H., et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's association and the American Geriatric Society. J Am Med Assoc 278 16 (1997) 1363-1371
30. Street J.S., Clark W.S., Gannon K.S., Cummings J.L., Bymaster F.P., Tamura R.N., et al. Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer disease in nursing care facilities: double blind randomized, placebo controlled trial HGEU Study Group. Arch Gen Psychiatry 57 (2000) 968-976
31. Tariot P.N., and Ismail M.S. Use of quetiapine in elderly patients. J Clin Psychiatry 63 Suppl 13 (2002) 21-26
32. Tune L.E. Risperidone for the treatment of behavioral and psychological symptoms of dementia. J Clin Psychiatry 62 Suppl 21 (2001) 29-32
33. Workman J.R.H., Orengo C.A., Bakey A.A., Molinari V.A., and Kunik M.E. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 9 4 (1997) 594-597